Future Capital

MegaRobo is an AI and robotics company that specializes in the fields of life sciences, clinical diagnosis, and applied chemistry. They focus on the research and development of robotics and artificial intelligence technology and deeply integrate it into industry applications to provide customers with advanced intelligent automation products and solutions. MegaRobo was founded in 2016 and is based in Beijing, China.

Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

Bishi Technology is a tech enterprise in the field of intelligent operation and maintenance, Biztech has always been committed to providing enterprise users with easy-to-use and stable intelligent operation and maintenance products. Biz intelligent operation and maintenance platform is based on machine learning algorithms, helping large enterprise data centers to find faults in advance, locate fault ranges, predict trends in massive monitoring data, reduce mean time to repair (MTTR) and prolong system trouble-free running time (MTBF) , improve system availability and operation and maintenance efficiency.

Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of precise heatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.

ClickPaaS is a provider of low code development platform products and solutions based on hpaPaaS that helps SaaS enterprises, consulting firms, and enterprise customers to significantly reduce response times and costs for complex business requirements. ClickPaaS is an innovative technology platform company dedicated to the development and service of the highly productive aPaaS platform, providing fast, high-quality technology platforms for government companies, consulting companies, startups and professional partners.

Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.

Lixiang, formerly known as Chehejia (“Car and Home”), is a Beijing-based electric vehicle startup that plans to disrupt the transportation and auto industries through complete vertical integration. It designs, researches, manufactures, sells, and offers services featuring a few models of electric vehicles. It makes products including smart EVs and electric SUVs to provide customers with longer crosstown journeys. Lixiang also offers rental services and Uber-like on-demand ride-hailing. It was founded in 2015.

Missevan is a domestic leading secondary audio community.

Yihang.ai manufactures autonomous driving systems. Yihang Intelligent provides the host factory with a complete auto-driving solution with high reliability, high quality and low cost. Since its establishment, Yihang Intelligent has been aiming at productization and strictly follows the development process of the main engine factory. At present, Autopilot has been commercialized, and Autopilot function autopilot solution is provided for a certain production model. It is applied to Level 4 deep learning technology research and development. Breakthroughs have also been made to achieve real-time pixel-level image segmentation based on deep learning on a car-level embedded chip. Yihang intelligent team is proficient in artificial intelligence and core algorithms such as sensing, decision-making, control and fault diagnosis. It integrates the elites of the automotive industry and experts in computer vision and deep learning. The team members are from domestic and foreign OEMs, Tier 1 suppliers, domestic and foreign. Leading scientific research institutions and famous universities at home and abroad such as Berkeley and Cambridge.It began operation in 2015, with its headquarters in Beijing in China.

Nongfenqi, a rural internet finance services platform.Run by Nanjing Nongfenqi E-Commerce Co. Ltd., provides installment payment services to large farming groups and collaborative communes on their agricultural equipment purchases. The company has provided services to 20,000 clients so far, the report added.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

3-G International develops software-based smart card, biometric, and card management solutions. The company was founded in 1982 and is headquartered in Springfield, Virginia.